Family Management’s NanoViricides NNVC Stock Holding History

Family Management’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-707	Closed	-$3K	–	193
2019 Q2	$3K	Hold	707	–	–	﹤0.01%	175
2019 Q1	$4K	Buy	+707	New	+$4.61K	﹤0.01%	132

Other funds holding NNVC

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Family Management's NNVC Position: Q3 2019 in Review

Family Management sold out of NanoViricides (NNVC) in Q3 2019, closing a stake of 707 shares — an estimated $3K sold.

Family Management first reported a position in NNVC in Q1 2019 and held it in 2 quarters. The position peaked at $4K in Q1 2019. 17 funds tracked by Wall St. Rank hold NNVC as of Q3 2019.

Family Management reported no remaining NanoViricides position as of Q3 2019 after selling out during the quarter.
Family Management sold 707 NanoViricides shares in Q3 2019, an estimated $3K.
Family Management first reported a position in NanoViricides in Q1 2019 and held it in 2 quarters.
Family Management's NanoViricides position peaked at $4K in Q1 2019.
17 funds tracked by Wall St. Rank held NanoViricides as of Q3 2019.

Based on Family Management's 13F filing for Q3 2019, filed 12 Nov 2019.